Verisign [VRSN] vs Oracle [ORCL] Detailed Stock Comparison
Verisign
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Verisign wins in 13 metrics, Oracle wins in 7 metrics, with 0 ties. Verisign appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Verisign | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 32.04 | 58.19 | Verisign |
| Price-to-Book Ratio | -12.79 | 34.66 | Verisign |
| Debt-to-Equity Ratio | -0.90 | 519.59 | Verisign |
| PEG Ratio | 31.01 | 35.27 | Verisign |
| EV/EBITDA | 23.44 | 34.39 | Verisign |
| Profit Margin (TTM) | 50.03% | 21.68% | Verisign |
| Operating Margin (TTM) | 68.48% | 32.48% | Verisign |
| EBITDA Margin (TTM) | 68.48% | 32.48% | Verisign |
| Return on Equity | -40.13% | 82.38% | Oracle |
| Return on Assets (TTM) | 46.56% | 7.26% | Verisign |
| Free Cash Flow (TTM) | $874.50M | $-394.00M | Verisign |
| Dividend Yield | 0.50% | 0.81% | Oracle |
| 1-Year Return | 56.12% | 94.18% | Oracle |
| Price-to-Sales Ratio (TTM) | 15.68 | 12.36 | Oracle |
| Enterprise Value | $26.26B | $807.58B | Oracle |
| EV/Revenue Ratio | 16.43 | 14.07 | Oracle |
| Gross Profit Margin (TTM) | 88.02% | 70.19% | Verisign |
| Revenue per Share (TTM) | $17 | $21 | Oracle |
| Earnings per Share (Diluted) | $8.37 | $4.34 | Verisign |
| Beta (Stock Volatility) | 0.78 | 1.43 | Verisign |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Verisign vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Verisign | -0.81% | 1.90% | -4.70% | -4.66% | 23.76% | 33.59% |
| Oracle | 0.28% | -1.73% | 7.38% | 66.96% | 42.95% | 50.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Verisign | 56.12% | 35.20% | 31.81% | 284.33% | 857.66% | 1,068.11% |
| Oracle | 94.18% | 223.98% | 373.12% | 550.67% | 1,031.64% | 1,828.05% |
Performance & Financial Health Analysis: Verisign vs Oracle
| Metric | VRSN | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $25.05B | $709.31B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 1,485,027 | 9,447,430 |
| 90 Day Avg. Volume | 898,416 | 13,061,150 |
| Last Close | $271.77 | $250.10 |
| 52 Week Range | $172.49 - $310.60 | $118.86 - $260.87 |
| % from 52W High | -12.50% | -4.13% |
| All-Time High | $310.60 (Jul 28, 2025) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -12.50% | -4.13% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.11% |
| Quarterly Earnings Growth | 0.04% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.50% | 0.22% |
| Operating Margin (TTM) | 0.68% | 0.32% |
| Return on Equity (TTM) | -0.40% | 0.82% |
| Debt to Equity (MRQ) | -0.90 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-21.30 | $7.29 |
| Cash per Share (MRQ) | $6.36 | $3.99 |
| Operating Cash Flow (TTM) | $978.70M | $20.82B |
| Levered Free Cash Flow (TTM) | $753.86M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.50% | 0.81% |
| Last 12-Month Dividend | $1.54 | $1.70 |
Valuation & Enterprise Metrics Analysis: Verisign vs Oracle
| Metric | VRSN | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 32.04 | 58.19 |
| Forward P/E | 31.01 | 35.27 |
| PEG Ratio | 31.01 | 35.27 |
| Price to Sales (TTM) | 15.68 | 12.36 |
| Price to Book (MRQ) | -12.79 | 34.66 |
| Market Capitalization | ||
| Market Capitalization | $25.05B | $709.31B |
| Enterprise Value | $26.26B | $807.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 16.43 | 14.07 |
| Enterprise to EBITDA | 23.44 | 34.39 |
| Risk & Other Metrics | ||
| Beta | 0.78 | 1.43 |
| Book Value per Share (MRQ) | $-21.30 | $7.29 |
Financial Statements Comparison: Verisign vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VRSN | ORCL |
|---|---|---|
| Revenue/Sales | $402.30M | $15.90B |
| Cost of Goods Sold | $49.40M | $4.74B |
| Gross Profit | $352.90M | $11.16B |
| Research & Development | $26.00M | $2.65B |
| Operating Income (EBIT) | $271.20M | $5.19B |
| EBITDA | $287.60M | $7.00B |
| Pre-Tax Income | $258.40M | $4.15B |
| Income Tax | $59.10M | $725.00M |
| Net Income (Profit) | $199.30M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VRSN | ORCL |
|---|---|---|
| Cash & Equivalents | $575.40M | $10.79B |
| Total Current Assets | $714.10M | $24.58B |
| Total Current Liabilities | $1.29B | $32.64B |
| Long-Term Debt | $1.79B | $96.83B |
| Total Shareholders Equity | $-1.98B | $20.97B |
| Retained Earnings | $-12.40B | $-15.48B |
| Property, Plant & Equipment | $221.50M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VRSN | ORCL |
|---|---|---|
| Operating Cash Flow | $294.90M | $5.93B |
| Capital Expenditures | $-5.80M | N/A |
| Free Cash Flow | $285.50M | $-2.92B |
| Debt Repayment | $-500.00M | $-6.07B |
| Common Stock Repurchase | $-241.70M | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | VRSN | ORCL |
|---|---|---|
| Shares Short | 1.75M | 20.68M |
| Short Ratio | 2.65 | 1.27 |
| Short % of Float | 0.03% | 0.01% |
| Average Daily Volume (10 Day) | 1,485,027 | 9,447,430 |
| Average Daily Volume (90 Day) | 898,416 | 13,061,150 |
| Shares Outstanding | 95.00M | 2.81B |
| Float Shares | 92.54M | 1.64B |
| % Held by Insiders | 0.10% | 0.42% |
| % Held by Institutions | 0.82% | 0.45% |
Dividend Analysis & Yield Comparison: Verisign vs Oracle
| Metric | VRSN | ORCL |
|---|---|---|
| Last 12-Month Dividend | $1.54 | $1.70 |
| Last 12-Month Dividend Yield | 0.50% | 0.81% |
| 3-Year Avg Annual Dividend | $0.51 | $1.55 |
| 3-Year Avg Dividend Yield | 0.27% | 0.36% |
| 3-Year Total Dividends | $1.54 | $4.66 |
| Ex-Dividend Date | Aug 19, 2025 | Apr 10, 2025 |